肺癌患者呼出气冷凝液中的生物标志物及其意义  

Biomarkers and their significance in exhaled breath condensate of lung cancer

作　　者：郝帅源 黄平[1] 

机构地区：[1]广东医学院附属南山医院呼吸内科,深圳518052

出　　处：《国际呼吸杂志》2016年第1期43-46,共4页International Journal of Respiration

摘　　要：目前肿瘤的早期诊断，特别是非侵入性的早期诊断方法，逐渐受到重视。呼出气冷凝液作为一种新型检测肺癌的方法，因其收集简单、非侵入性等优点越来越成为研究的焦点。对肺癌患者呼出气冷凝液中生物标志物进行研究有助于辅助肺癌早期诊断，且在病情评估、疗效评价、预后估计等方面也起到重要作用。1 At present, the early diagnosis of tumor, especially the non-invasive diagnosis method, is gradually valued. As a new way of detecting lung cancer, exhaled breath condensate is now becoming the focus of research because it is easy to collection and non-invasive. Analyzing biomarkers in exhaled breath condensate of lung cancer patients could be helpful for the early diagnosis of lung cancer and evaluation of therapeutic response and prognosis.

关 键 词：呼出气冷凝液 肺癌 生物标志物 

分 类 号：R734.2[医药卫生—肿瘤]